Page 3 - Preference Centre News Today

Results from the clinical development programme developed with Protalix BioTherapeutics evaluating pegunigalsidase alfa (PRX-102) an investigational enzyme...

/PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has received clearance to conduct...

The question debated was, should patients with hemophilia A stick with effective nonfactor therapy or join a clinical trial for a potential cure with gene therapy?

Expanding the role of advanced medical content in clinical outcome improvement is at the heart of a cooperation between Oslo University Hospital and Olympus, which will also builds the foundation for the development of AI in digital health solutions.

A new National Environmental (eDNA) Reference Centre will support the next generation of cutting-edge tools for Australia’s biosecurity system. The

20.01.2022 - EQS-Ad-hoc: Medacta Group SA / Key word(s): Sales Result Medacta Group SA reports strong revenue growth of 21.4% in 2021 20-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the ... Seite 1

EQS-Ad-hoc: Medacta Group SA / Key word(s): Sales Result Medacta Group SA reports strong revenue growth of 21.4% in 2021 20-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant

EQS-Ad-hoc: Medacta Group SA / Key word(s): Sales Result Medacta Group SA reports strong revenue growth of 21.4% in 2021 20-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to

The country’s Ambassador, Filippo Scammacca del Murgo and wife paid a courtesy visit to the research centre yesterday November 23, 2021.

The country’s Ambassador, Filippo Scammacca del Murgo and wife paid a courtesy visit to the research centre yesterday November 23, 2021.